 |
|
The Need for Global Action Against Multidrug-Resistant Tuberculosis
S. Jody Heymann, MD, PhD;
Timothy F. Brewer, MD, MPH;
Mary E. Wilson, MD;
Harvey V. Fineberg, MD, PhD
JAMA. 1999;281:2138-2140.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Imagine a new disease. It spreads by droplet nuclei. Humans carry it from one country to another. The disease infects both healthy persons and those with compromised immune systems. For every person evidently ill, 10 to 20 are infected silently, and as many as 10% per year of those who are immunocompromised will develop active disease and spread the infection. The disease is curable with drugs that are available in industrialized countries but considered too expensive for developing countries. Left untreated, the disease is likely to affect tens of millions worldwide and kill at least half of those who develop active disease. It seems clear that the global health community would make an urgent commitment to fight such a disease, if there were an opportunity to stop it early in its . . . [Full Text of this Article]
Author Affiliations: Harvard School of Public Health (Drs Heymann and Wilson), the Channing Laboratory, Brigham and Women's Hospital, Department of Medicine (Dr Brewer), Harvard Medical School (Dr Wilson), and Harvard University (Dr Fineberg), Boston, Mass.
RELATED LETTER
Global Action Against Multidrug-Resistant Tuberculosis
Dean Schraufnagel, Jawid Abubaker, S. Jody Heymann, Timothy F. Brewer, Mary E. Wilson, and Harvey V. Fineberg
JAMA. 2000;283(1):54-55.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Direct Detection of Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis in Auramine-Rhodamine-Positive Sputum Specimens by Real-Time PCR
Ruiz et al.
J. Clin. Microbiol. 2004;42:1585-1589.
ABSTRACT
| FULL TEXT
New Real-Time PCR Able To Detect in a Single Tube Multiple Rifampin Resistance Mutations and High-Level Isoniazid Resistance Mutations in Mycobacterium tuberculosis
Garcia de Viedma et al.
J. Clin. Microbiol. 2002;40:988-995.
ABSTRACT
| FULL TEXT
Evaluation of Etest for Susceptibility Testing of Multidrug-Resistant Isolates of Mycobacterium tuberculosis
Hazbón et al.
J. Clin. Microbiol. 2000;38:4599-4603.
ABSTRACT
| FULL TEXT
Global Action Against Multidrug-Resistant Tuberculosis
Schraufnagel et al.
JAMA 2000;283:54-55.
FULL TEXT
Political economy of technology transfer
Donald
BMJ 1999;319:1298-1298.
FULL TEXT
|
